Dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(Biphenyl-4,4'-Diyl)Bis(1H-Imidazole-4,2-Diyl))Bis(Pyrrolidine-2,1-Diyl))Bis(3-Methyl-1-Oxobutane-2,1-Diyl)Dicarbamate

In the rhodium-catalyzed asymmetric hydrogenation of prochiral aryl alkyl ketones, the chiral tetradentate bis(imidazoline) ligand serves as the stereochemical control element when coordinated to a [Rh(nbd)₂]BF₄ precursor in anhydrous methanol. Pre-drying of the solvent over activated 3 Å molecular sieves to a water content below 50 ppm by Karl Fischer titration is mandatory; residual moisture causes irreversible ligand displacement and loss of enantioselectivity. A ligand-to-rhodium ratio of 1.05:1 is charged into a 300 mL Hastelloy C‑276 autoclave equipped with a hollow‑shaft gas‑entrainment impeller and external heating jacket. After three argon‑purge cycles, the substrate (e.g., 4′‑chloroacetophenone, 0.5 M in MeOH) is injected, and hydrogen is introduced to a constant pressure of 20 bar while stirring at 1200 rpm at 40 °C. Reaction progress is monitored by withdrawing samples through a dip tube, quenching with silica‑bound diamine, and injecting onto an Agilent 7890B GC equipped with a Beta DEX 225 chiral capillary column (30 m × 0.25 mm i.d., 0.25 μm film) operated with helium carrier at 1.5 mL/min and a split ratio of 50:1. Under these conditions the enantiomeric excess of the (S)-1-(4-chlorophenyl)ethanol product consistently exceeds 98% at full conversion within 90 minutes, as confirmed by independent standard spiking and VCD absolute configuration assignment. The catalyst displays robust productivity; a single batch of the in‑situ generated complex achieves turnover numbers exceeding 10 000 before deactivation, provided strictly oxygen‑free conditions are maintained. A typical work‑up involves filtration through a 0.2 μm PTFE membrane, solvent swap to n‑heptane, and distillation under reduced pressure (85 °C pot temperature, 5 mbar) to yield product with chemical purity ≥99.5% by HPLC (C18, 250 mm × 4.6 mm, acetonitrile/water 60:40, UV‑220 nm, per USP ⟨621⟩). Operational boundaries: contact with stainless steel surfaces at elevated temperature in the presence of chloride ions can promote ligand degradation; all wetted parts of the reactor are specified in Hastelloy or PTFE. The isolated ligand must be stored under argon at −20 °C and protected from light to prevent photo‑oxidation of the imidazoline rings; any discoloration from off‑white to yellow denotes activity loss exceeding 15% ee.

What Process Parameters Govern Enantioselectivity in Palladium‑Catalyzed Allylic Alkylation?

Employing the dicarbamate‑protected bis(imidazoline) ligand in Pd‑catalyzed asymmetric allylic substitution of rac‑1,3‑diphenyl‑2‑propenyl acetate with dimethyl malonate requires precise control over ligand‑to‑palladium stoichiometry, the nature of the silylating agent, and the base. The resting state of palladium is generated by combining [Pd(η³‑C₃H₅)Cl]₂ with the ligand in degassed dichloromethane at 25 °C for 30 minutes under argon, followed by filtration to remove chloride‑bridged oligomers. The substrate (1.0 mmol scale) is treated with dimethyl malonate (3.0 equiv), N,O‑bis(trimethylsilyl)acetamide (BSA, 3.0 equiv), and anhydrous potassium acetate (0.05 equiv) in CH₂Cl₂, and the pre‑formed catalyst solution is added at 0 °C. Enantioselectivity is critically dependent on the base counter‑ion; potassium acetate consistently outperforms sodium acetate and tetramethylammonium acetate in terms of both reaction rate and ee, likely due to favourable solubility of the in‑situ generated silyl ester. Finished reaction mixtures are quenched with saturated NH₄Cl, extracted with dichloromethane, and analysed for enantiomeric composition by chiral stationary‑phase HPLC on a Chiralpak AD‑H column (250 mm × 4.6 mm, hexane/2‑propanol 90:10, 1.0 mL/min, UV‑254 nm). A systematic variation of the ligand‑to‑Pd ratio, while holding the initial palladium dimer concentration constant, reveals a sharp optimum; the data are summarised in the table below. At the optimum ratio, the (R)‑enantiomer of the alkylated malonate is obtained in 94% ee and 88% isolated yield after flash chromatography on silica gel (hexane/ethyl acetate 85:15). Process robustness is challenged when protic impurities exceed 100 ppm in the starting acetate; pre‑treatment of the substrate with activated basic alumina is therefore a mandatory in‑process control. Extended reaction times beyond 4 h lead to racemization via palladium‑catalysed epimerisation of the product, a phenomenon documented through re‑subjection experiments.

Asymmetric cyclopropanation of alkenes with α‑diazo esters catalysed by copper(I) complexes of tetradentate bis(imidazoline) ligands provides direct access to chiral cyclopropane carboxylic esters that serve as building blocks for pyrethroid insecticides and pharmaceutical C1‑synthons. The catalyst is generated by stirring the ligand (5 mol %) with CuOTf·0.5 C₆H₆ (5 mol %) in dichloromethane at room temperature for 1 h, followed by filtration to remove excess insoluble copper salt. A solution of styrene (1.0 equiv) and a small quantity of hydroquinone (0.5 mol %) as radical inhibitor is charged into a jacketed reactor, and a degassed solution of ethyl diazoacetate (1.2 equiv in CH₂Cl₂) is added via syringe pump over 4 h at 25 °C to avoid accumulation of the thermally sensitive diazo compound. The exothermic nature of the reaction necessitates active jacket temperature control to maintain an internal range of 22–28 °C; excursion above 35 °C leads to runaway decomposition of the diazo ester, releasing N₂ and forming tars that poison the catalyst. After complete addition, the mixture is stirred for an additional 30 minutes, concentrated in vacuo below 30 °C, and the crude cyclopropane mixture is analysed by GC on a Cyclosil‑B column (30 m × 0.25 mm × 0.25 μm) to determine the cis/trans ratio and enantiomeric excesses. Literature precedents with structurally related C₂‑symmetric bis(imidazoline) ligands indicate that the trans isomer is obtained in 70–80% diastereomeric excess, with ee values of the trans enantiomer falling in the range 90–95%. Isolation of the chiral cyclopropane ester is accomplished by vacuum distillation (bp 72 °C at 4 mbar) using a short‑path distillation head to minimise thermal epimerisation. Operational boundaries are rigid: the diazo ester must be stored at −20 °C and handled behind a blast shield; contact with heavy‑metal salts, including copper in the +2 oxidation state, initiates uncontrolled carbene generation. A thorough post‑reaction analysis by GC‑MS is required to confirm the absence of residual ethyl diazoacetate before any waste stream is discharged; residual diazo content must be below 100 ppm per site safety protocol aligned with OSHA 29 CFR 1910.119.

When the Substrate Is a Sterically Hindered α,β‑Unsaturated Ester — Conjugate Addition Optimization

Conjugate addition of trimethylaluminium to acyclic and cyclic enones can be rendered enantioselective by employing copper‑bis(imidazoline) catalysts generated from Cu(OTf)₂ and the dicarbamate‑protected ligand in diethyl ether. The substrate scope profoundly influences both reaction rate and the optimal ligand‑to‑copper ratio. In the case of 2‑cyclopenten‑1‑one, a standard benchmark enone, the catalyst is prepared by mixing Cu(OTf)₂ (2 mol %) and the ligand (2.4 mol %) in anhydrous Et₂O at −40 °C for 20 minutes. Trimethylaluminium (1.5 equiv, 2 M solution in toluene) is added dropwise over 15 minutes under argon to form the nucleophilic organocopper species in situ. The enone (1.0 equiv in Et₂O) is then introduced slowly, and the mixture is stirred for 3 h while the temperature is strictly maintained at −40 ± 2 °C. Quenching with saturated NH₄Cl and extraction with methyl tert‑butyl ether yields (R)‑3‑methylcyclopentanone, whose enantiomeric purity reaches 91–93% ee as determined by chiral GC analysis after derivatization with (2R,4R)‑2,4‑pentanediol (formation of the cyclic ketal). When the substrate is changed to tert‑butyl cinnamate, a sterically demanding acyclic α,β‑unsaturated ester, the optimal ligand loading shifts to 3.0 mol % relative to Cu(OTf)₂ at 2 mol %, and the reaction must be conducted in toluene instead of diethyl ether to achieve homogeneous mixing; under these conditions the Michael adduct is obtained with an ee of 88% after column chromatography. A critical process constraint is the moisture content of the alkylaluminium reagent; hydrolysis generates methane and aluminium hydroxide gels, irreversibly sequestering the ligand and quenching the catalytic cycle. Commercially supplied trimethylaluminium solution must be titrated immediately before use following the method of Barr et al. (J. Am. Chem. Soc. 1988, 110, 8526) to verify concentration and freedom from pre‑hydrolysed species. Strict compliance with REACH restriction entry 28 (Appendix 1–5) governs the handling of organoaluminium compounds; any scale‑up beyond 1 kg batch size requires additional HAZOP review on the manufacturing site.

Resolution of racemic 2‑arylpropionic acids, key intermediates for non‑steroidal anti‑inflammatory drugs such as (S)‑ibuprofen and (S)‑naproxen, can be accomplished through diastereomeric salt formation with enantiopure (2S,2′S)‑configured bis(imidazoline) ligand as a chiral base. The ligand’s four nitrogen centres are partially protonated upon addition of one equivalent of the racemic acid in a 1:1 molar ratio in ethyl acetate, leading to precipitation of the less soluble (S)‑acid·(S,S)‑ligand salt pair. Process development on a 100 mmol scale demonstrates optimal resolution efficiency when the crystallisation is initiated by dissolving the ligand and the racemic acid in ethyl acetate at 60 °C, followed by controlled cooling to 5 °C at a rate of 0.5 °C min⁻¹ with gentle stirring. The crystalline salt is filtered, washed with cold ethyl acetate/heptane (1:2), and dried under vacuum at 40 °C to a constant weight. Liberation of the enantiomerically enriched acid is performed by partitioning the salt between 1 M HCl and dichloromethane; the organic phase yields acid with an enantiomeric excess of >98% after single crystallisation, determined by chiral HPLC on a Chiralpak QD‑AX column (aqueous ammonium acetate/methanol, UV‑230 nm). The recovered ligand from the mother liquor can be regenerated in 85–90% yield by neutralisation with aqueous NaOH, extraction, and recrystallisation from acetonitrile, meeting purity specifications of ≥99% area by HPLC. A limitation of this resolution protocol is its poor performance with acids bearing electron‑rich aryl rings; the induced diastereomeric discrimination drops below a thermodynamically useful level for substrates such as 2‑(4‑methoxyphenyl)propionic acid, where the eutectic composition deviates only 5% from the racemic mixture. Additionally, the ligand must be protected from exposure to carbon dioxide during salt formation because carbamate formation on the pyrrolidine nitrogen sites erodes basicity and alters crystallisability; argon‑sparged solvents and a closed crystalliser are mandatory equipment.

Bifunctional Linker for Homochiral Metal‑Organic Frameworks in Enantioselective Chromatography

The dicarbamate derivative of the biphenyl‑diimidazoline‑dipyrrolidine scaffold acts as a tetratopic N‑donor linker in the construction of homochiral metal‑organic frameworks (MOFs) with Zn²⁺ or Cd²⁺ nodes, yielding porous crystalline solids capable of enantioselective guest inclusion. Solvothermal reaction of the ligand (0.05 mmol) with Zn(NO₃)₂·6 H₂O (0.10 mmol) in DMF/EtOH/H₂O (3:1:1 v/v/v, total 5 mL) at 85 °C for 48 h in a Teflon‑lined autoclave produces hexagonal‑prism crystals of the resultant framework. Single‑crystal X‑ray diffraction confirms a layered two‑dimensional net with interlayer channels of approximate diameter 8.2  Å, lined with pendant imidazoline and carbamate groups that serve as chiral recognition pockets. After activation by solvent exchange with anhydrous acetone and evacuation at 120 °C for 12 h under dynamic vacuum (10⁻³ mbar), the material exhibits a BET surface area of 420 m² g⁻¹ as measured by N₂ adsorption at 77 K. For chromatographic evaluation, the activated crystals are ground and sieved to a particle size of 30–50 μm, then slurry‑packed into a stainless‑steel HPLC column (150 mm × 4.0 mm i.d.) under 400 bar using hexane as the push solvent. Baseline separation of racemic 1‑phenylethanol is achieved with a mobile phase of hexane/2‑propanol (95:5) at 0.5 mL min⁻¹; the resolution factor R_s reaches 2.8 and the (R)‑enantiomer elutes first, confirmed by spiking with an optically pure standard. Column stability is maintained for over 500 injections provided the mobile phase water content is below 0.05% (monitored by Karl Fischer titration of eluent). A severe operational boundary is imposed by the framework’s sensitivity to aqueous acidic or basic conditions; contact with methanol/water mixtures above 10% water leads to gradual dissolution of the zinc‑based framework, evidenced by a rise in column back‑pressure and loss of enantioselectivity. The use of this MOF as a stationary phase demands adherence to ICH guideline Q3C for residual solvents when employed in API‑grade chiral separations, with comprehensive method validation per ISO 17025:2017 clause 7.2 for non‑routine testing.